The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are more effective in the same indications was impressive -- and is one of the ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes ...

Humira is a brand-name drug prescribed to treat rheumatoid arthritis, psoriatic arthritis, and more. It can remain unrefrigerated for up to 14 days, as long as the temperature doesn’t go above 77°F ...

The Trump administration is staging a major shake-up at Immigration and Customs Enforcement, with plans to reassign senior leaders in agency offices across the country amid frustrations over current ...

Oct 20 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a head-to-head . AbbVie has been ...

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira, meeting the main goal of a head-to-head trial. NFL Week 16 INSTANT ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File ...

AbbVie ABBV expects to return to robust revenue growth in 2025, despite the U.S. loss of exclusivity (LOE) for its flagship drug Humira over two years ago. The drug, which went off-patent in January ...

As the dominance of its legendary “blockbuster drug” Humira fades, its creator, AbbVie Inc. (NYSE: ABBV), is charting a bold new course. Facing challenges from potential tariffs and R&D uncertainties, ...